IRINA SALABAI: Open Payments
NPI 1194324053 · ALGONQUIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,633 in 36 payments from 16 companies in 2025. Trend: 2023 $1,860 · 2024 $3,034 · 2025 $3,633
Food & beverage: $3,633
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $823 |
| Otsuka America Pharmaceutical, Inc. | 3 | $257 |
| Alkermes, Inc. | 2 | $248 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $241 |
| Vanda Pharmaceuticals Inc. | 2 | $240 |
| Neurocrine BioSciences, Inc. | 2 | $238 |
| Axsome Therapeutics, Inc. | 2 | $237 |
| Janssen Biotech, Inc. | 2 | $231 |
| Janssen Pharmaceuticals, Inc | 2 | $227 |
| Teva Pharmaceuticals USA, Inc. | 2 | $216 |
Products named: VRAYLAR, REXULTI, LYBALVI, CAPLYTA, FANAPT, INGREZZA, Auvelity, SPRAVATO.
Industry payments across IL — which companies pay providers there.
